Sandu Pharmaceuticals Ltd

KYC updation and transfer-deed window

• Intimates physical shareowners to furnish PAN, address, mobile, bank details, signature per SEBI master circular.
• Forms and KYC formats available on company and MUFG Intime websites.
• Special window for re-lodgement of transfer deeds opens Feb 5, 2026 to Feb 4, 2027.
• During window, transfer requests will be issued only in demat mode.
• Non-updation may result in electronic dividend payments from April 01, 2024.
• Shareholders urged to convert physical holdings to demat.
• Submit hard copies via MUFG Intime India Private Limited, RTA.

Sandu Pharmaceuticals Ltd: Trading Window Closure

Balram Viswanathan: CMD redesignation

• Redesignated as CMD; effective 11 July 2026; 3-year term; profile: B.Com, FCA, CPA (USA); 30+ yrs exp.

Dr Neeti Madan Kapre: NED appointment

• Appointed as Non-Executive Independent Director for five years from 11 July 2026; profile: MBBS Gold Medal; MS ENT.

AGM Details

• Date and time: 11 September 2026 at 4:30 pm via VC/OAVM.

Key Resolutions and Outcomes

• Resolution 1: Adopt Audited Standalone Financial Statements for FY ending 31 March 2026; passed.
• Resolution 2: Reappoint Jayashree Sandu by rotation; passed.
• Resolution 3: Declare dividend on equity shares for FY ending 31 March 2026; passed.
• Resolution 4: Appoint M/s Dave & Dave as Statutory Auditors for five years; passed.
• Resolution 5: Ratify Cost Auditor's remuneration; passed.
• Resolution 6: Approve Material Related Party Transaction with Sandu Brothers Private Limited; passed.
• Resolution 7: Redesignate Balram Viswanathan as Chairman and Managing Director; passed.
• Resolution 8: Appoint Dr Neeti Kapre as Non-Executive Independent Director; passed.

Governance & Related Parties

• Statutory Auditor appointment: M/s Dave & Dave for five-year term.
• Cost Auditor remuneration ratified.
• Related Party Transaction with Sandu Brothers Private Limited approved.

Dividend Details

• Dividend on equity shares declared for FY ended 31 March 2026; amount per share not disclosed.

AGM Details

• Held on 11 Sep 2026 at 04:30 PM, via VC/OAVM.
• Concluded at 05:01 PM.
• Remote e-voting from 08 Sep 2026 10:00 AM to 10 Sep 2026 05:00 PM.
• Post-AGM voting available via NSDL for non-voters.
• Quorum present; meeting chaired by Balram Viswanathan; directors attended via VC.
• Annual report emailed to shareholders; available on company and BSE websites.

Resolutions & Voting

• Adopt audited standalone financial statements for year ended 31 March 2026 — deemed passed.
• Reappoint Jayshree Sandu by rotation as Director — deemed passed.
• Declare dividend on equity shares for FY ended 31 March 2026 — deemed passed.
• Appoint M/S Dave & Dave as Statutory Auditors for five years — deemed passed.
• Ratify Cost Auditor’s remuneration — deemed passed.
• Approve material related party transactions with Sandu Brothers Private Limited — deemed passed.
• Redesignate Balram Viswanathan as Chairman and Managing Director — deemed passed.

AGM notice and shareholder communications

• 41st AGM set for Sep 11, 2026 at 4:30 PM IST via VC/OAVM.
• Notice and FY2026-27 Annual Report sent electronically to shareholders with registered email.
• Annual Report for FY2025-26 available online; link sent to those without registered emails.
• Cut-off date for email registration: 07 August 2026.
• KYC updates and dematerialisation urged; ISR-1 to SH-14 forms on RTA site.

Financial performance

• FY2025-26 standalone revenue ₹6993.45 lakh, up from ₹6719.24 lakh.
• PAT ₹176.62 lakh; grew from ₹154.89 lakh YoY.
• Basic and diluted EPS ₹1.83 per share.
• Total comprehensive income ₹242.96 lakh; OCI ₹66.34 lakh.
• Operating cash flow ₹611.55 lakh; cash position healthy.

Dividend & capital allocation

• Final dividend proposed ₹1.00 per equity share for FY2025-26.
• Record date set at 4 Sep 2026; payout subject to AGM approval.
• Dividend to be paid electronically as per SEBI norms.

Shareholding & capital structure

• Paid-up share capital ₹966.10 lakh (9,660,990 shares).
• Promoter group holds 42.90% as at 31-Mar-2026.
• Top holders include Umesh Sandu, Shashank Sandu, Jayshree Sandu.
• Dematerialised shares are 91.89% of total as at 31-Mar-2026.

Governance & leadership

• MD Shri Umesh Sandu passed away on 19 Jun 2026; Balram Viswanathan appointed MD from 11 Jul 2026.
• Smt Jayshree Sandu reappointed; Dr Neeti Kapre appointed independent director.
• Board now comprises three independent directors; independence declarations on record.

Audit & controls

• Statutory auditors M/s Dave & Dave appointed for five years.
• Cost auditor remuneration ₹1.30 lakh per annum ratified.
• Standalone audit unqualified; revenue recognition policy disclosed.
• Secretarial audit by Swapnil Dixit; no material observations.

Related party transactions

• Material RPT with Sandu Brothers Private Limited; aggregate value up to ₹2.96 crore.
• RPTs are at arm's length and in ordinary course; oversight by Audit Committee.
• Disclosures in Form AOC-2 accompanying the notice.

Risks & outlook

• Outlook remains reasonably positive; Ayush initiatives support growth.
• Raw material cost pressures and regulatory environment could impact profitability.

Other material items

• AGM conducted via VC/OAVM; integrated annual report available online.
• CSR not applicable; IT security measures in place; no post-year material events.